LHC Group (LHCG) is a financially sound national provider of post-acute care, offering quality and cost-effective healthcare to patients within the comfort of their home. After a more than 12% drop last Friday, the shares of LHC Group are trading at a market cap of $328.98 million, which is close to the company's book value of $274.59 million. In this article I'll explain why the recent drop in the share price offers an incredible buying opportunity for medium-term investors, with a moderate risk-tolerance level. I believe the stock has very limited downside of not more than 5% from the current level against an approximately 40% potential upside within the next year.
Why Does This Opportunity Exist?
Only subscribers can access this article, which is part of the PRO research library covering 3,612 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: